| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Thematic Review |
-hydroxylase: BAREly missing a SHP
Correspondence to: Roger A. Davis, To whom correspondence should be addressed., rdavis{at}sciences.sdsu.edu (E-mail)
Cholesterol-7-hydroxylase (CYP7A1) regulates the pathway through which cholesterol is converted into bile acids. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. The discovery of farnesoid X receptor (FXR), the nuclear receptor activated specifically by bile acids, has opened new insights into these mechanisms. Bile acid activation of FXR has been shown to repress the expression of CYP7A1 via increasing the expression of small heterodimer partner (SHP), a non-DNA binding protein. The increased abundance of SHP causes it to associate with liver receptor homolog (LRH)-1, an obligate factor required for transcription of CYP7A1. Recent studies show there is an "FXR/SHP-independent" mechanism that also represses CYP7A1 expression. This "FXR/SHP-independent" pathway involves the interaction of bile acids with liver macrophages (i.e., Kupffer cells), which induces the expression, and secretion of cytokines.
These inflammatory cytokines, which include tumor necrosis factor and interleukin-1ß, act upon liver parenchymal cells causing a rapid repression of the CYP7A1 gene.—Davis, R. A., J. H. Miyake, T. Y. Hui, and N. J. Spann. Regulation of cholesterol-7-hydroxylase: BAREly missing a SHP. J. Lipid Res. 2002. 43: 533–543.
Supplementary key words: bile acid biosynthesis, FXR, cytokines
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. T. Flowers, M. P. Keller, Y. Choi, H. Lan, C. Kendziorski, J. M. Ntambi, and A. D. Attie Liver gene expression analysis reveals endoplasmic reticulum stress and metabolic dysfunction in SCD1-deficient mice fed a very low-fat diet Physiol Genomics, May 9, 2008; 33(3): 361 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Song, R. Kaimal, B. Yan, and R. Deng Liver receptor homolog 1 transcriptionally regulates human bile salt export pump expression J. Lipid Res., May 1, 2008; 49(5): 973 - 984. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Donner, S. Schumacher, U. Warskulat, J. Heinemann, and D. Haussinger Obstructive cholestasis induces TNF-{alpha}- and IL-1 -mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp1a4, and Oatp1b2 Am J Physiol Gastrointest Liver Physiol, December 1, 2007; 293(6): G1134 - G1146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Deng, D. Yang, A. Radke, J. Yang, and B. Yan The Hypolipidemic Agent Guggulsterone Regulates the Expression of Human Bile Salt Export Pump: Dominance of Transactivation over Farsenoid X Receptor-Mediated Antagonism J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1153 - 1162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Das, M. E. Fernandez-Zapico, S. Cao, J. Yao, S. Fiorucci, R. P. Hebbel, R. Urrutia, and V. H. Shah Disruption of an SP2/KLF6 Repression Complex by SHP Is Required for Farnesoid X Receptor-induced Endothelial Cell Migration J. Biol. Chem., December 22, 2006; 281(51): 39105 - 39113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Baldan, L. Pei, R. Lee, P. Tarr, R. K. Tangirala, M. M. Weinstein, J. Frank, A. C. Li, P. Tontonoz, and P. A. Edwards Impaired Development of Atherosclerosis in Hyperlipidemic Ldlr-/- and ApoE-/- Mice Transplanted With Abcg1-/- Bone Marrow Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2301 - 2307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Ratliff, A. Gutierrez, and R. A. Davis Transgenic expression of CYP7A1 in LDL receptor-deficient mice blocks diet-induced hypercholesterolemia J. Lipid Res., July 1, 2006; 47(7): 1513 - 1520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. R. Sweeney, A. H. Moser, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold Decreased nuclear hormone receptor expression in the livers of mice in late pregnancy Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1313 - E1320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Deng, D. Yang, J. Yang, and B. Yan Oxysterol 22(R)-Hydroxycholesterol Induces the Expression of the Bile Salt Export Pump through Nuclear Receptor Farsenoid X Receptor but Not Liver X Receptor J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 317 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hirao, S. Arakawa, K. Watanabe, K. Ito, and T. Furukawa Effects of Restricted Feeding on Daily Fluctuations of Hepatic Functions Including P450 Monooxygenase Activities in Rats J. Biol. Chem., February 10, 2006; 281(6): 3165 - 3171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Inoue, A.-M. Yu, S. H. Yim, X. Ma, K. W. Krausz, J. Inoue, C. C. Xiang, M. J. Brownstein, G. Eggertsen, I. Bjorkhem, et al. Regulation of bile acid biosynthesis by hepatocyte nuclear factor 4{alpha} J. Lipid Res., January 1, 2006; 47(1): 215 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Asahina, H. Fujimori, K. Shimizu-Saito, Y. Kumashiro, K. Okamura, Y. Tanaka, K. Teramoto, S. Arii, and H. Teraoka Expression of the liver-specific gene Cyp7a1 reveals hepatic differentiation in embryoid bodies derived from mouse embryonic stem cells Genes Cells, December 1, 2004; 9(12): 1297 - 1308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sirvent, A. J. M. Verhoeven, H. Jansen, V. Kosykh, R. J. Darteil, D. W. Hum, J.-C. Fruchart, and B. Staels Farnesoid X receptor represses hepatic lipase gene expression J. Lipid Res., November 1, 2004; 45(11): 2110 - 2115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nishimaki-Mogami, M. Une, T. Fujino, Y. Sato, N. Tamehiro, Y. Kawahara, K. Shudo, and K. Inoue Identification of intermediates in the bile acid synthetic pathway as ligands for the farnesoid X receptor J. Lipid Res., August 1, 2004; 45(8): 1538 - 1545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Freeman, A. Kennedy, J. Wu, S. Bark, A. T. Remaley, S. Santamarina-Fojo, and H. B. Brewer Jr. The orphan nuclear receptor LRH-1 activates the ABCG5/ABCG8 intergenic promoter J. Lipid Res., July 1, 2004; 45(7): 1197 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. U. DE MARTINO, S. ALESCI, G. P. CHROUSOS, and T. KINO Interaction of the Glucocorticoid Receptor and the Chicken Ovalbumin Upstream Promoter-Transcription Factor II (COUP-TFII): Implications for the Actions of Glucocorticoids on Glucose, Lipoprotein, and Xenobiotic Metabolism Ann. N.Y. Acad. Sci., June 1, 2004; 1024(1): 72 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Jung, B. Hagenbuch, M. Fried, P. J. Meier, and G. A. Kullak-Ublick Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene Am J Physiol Gastrointest Liver Physiol, May 1, 2004; 286(5): G752 - G761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kang, N. J. Spann, T. Y. Hui, and R. A. Davis ARP-1/COUP-TF II Determines Hepatoma Phenotype by Acting as Both a Transcriptional Repressor of Microsomal Triglyceride Transfer Protein and an Inducer of CYP7A1 J. Biol. Chem., August 15, 2003; 278(33): 30478 - 30486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Prieur, H. Coste, and J. C. Rodriguez The Human Apolipoprotein AV Gene Is Regulated by Peroxisome Proliferator-activated Receptor-{alpha} and Contains a Novel Farnesoid X-activated Receptor Response Element J. Biol. Chem., July 3, 2003; 278(28): 25468 - 25480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Goodwin, M. A. Watson, H. Kim, J. Miao, J. K. Kemper, and S. A. Kliewer Differential Regulation of Rat and Human CYP7A1 by the Nuclear Oxysterol Receptor Liver X Receptor-{alpha} Mol. Endocrinol., March 1, 2003; 17(3): 386 - 394. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |
